ATTBF OTC
Abattis Bioceuticals Corp.
1W: -96.7%
1M: -96.7%
3M: -96.7%
YTD: -96.7%
1Y: -96.7%
3Y: -90.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume2,481
Avg Volume22,325
Beta1.77
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORobert G. Goodall
Employees48
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2014-05-29
Websiteabattis.com
625 Howe Street
Vancouver, BC V6C 2M6
CA
Vancouver, BC V6C 2M6
CA
808 650 3007
About Abattis Bioceuticals Corp.
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Latest News
No recent news
Recent Insider Trades
No insider trades found